NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year net income growth rate
Latest
11.20%
↑ 108% vs avg
Percentile
P69
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-148.89%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 11.20% |
| Q3 2025 | -7.89% |
| Q2 2025 | 33.90% |
| Q1 2025 | -227.18% |
| Q4 2024 | 153.28% |
| Q3 2024 | -21.07% |
| Q2 2024 | 3.07% |
| Q1 2024 | 14.64% |
| Q4 2023 | -6.69% |
| Q3 2023 | 9.62% |
| Q2 2023 | 1.53% |
| Q1 2023 | -103.31% |
| Q4 2022 | -26.08% |
| Q3 2022 | 50.20% |
| Q2 2022 | 9.76% |
| Q1 2022 | -8.93% |
| Q4 2021 | -6.22% |
| Q3 2021 | 10.45% |
| Q2 2021 | -23.30% |
| Q1 2021 | -22.17% |
| Q4 2020 | -245.96% |
| Q3 2020 | 92.01% |
| Q2 2020 | -426.96% |
| Q1 2020 | 70.98% |
| Q4 2019 | -242.60% |
| Q3 2019 | 27.35% |
| Q2 2019 | 15.78% |
| Q1 2019 | -63.50% |
| Q4 2018 | 46.21% |
| Q3 2018 | -99.46% |
| Q2 2018 | 7.06% |
| Q1 2018 | 16.52% |
| Q4 2017 | -15.34% |
| Q3 2017 | -8.87% |
| Q2 2017 | -77.41% |
| Q1 2017 | -173.90% |
| Q4 2016 | -4677.08% |
| Q3 2016 | 77.42% |
| Q2 2016 | -175.69% |
| Q1 2016 | 53.02% |